Jefferies Reiterates Buy Rating on Cigna Corp. (CI)

Loading...
Loading...
Jefferies & Company is out with a research report this morning, where it reiterates its Buy rating on Cigna Corp.
CI
; it has a $45.00 price target on the stock. The analysts cited two key drivers to their rating: 1) diversification and 2) international growth. They noted that CI derives only 20% of its profits from international operations, but the company intends to ramp that up over the next few years. The analysts also noted that Cigna's profitability is well-spread across four segments, providing outlets for growth in 2011 when reform implementation hits commercial plans. The analysts said, “Our $45 price target assumes a 9.6x multiple on our 2011 EPS estimate of $4.67. Cigna's funding issues will keep the stock at a discount to the 10.3x target multiple of its peers. We believe the combination of earnings growth and protection against reform risks can support multiple expansion.”
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareJefferies and CompanyManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...